✦ LIBER ✦

Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma

✍ Scribed by F. Silvestris; A. Romito; P. Fanelli; A. Vacca; F. Dammacco

Book ID: 105280183
Publisher: Springer
Year: 1995
Tongue: English
Weight: 777 KB
Volume: 70
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01696618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant human erythropoietin (Rhu-Ep

Recombinant human erythropoietin (Rhu-Epo) therapy in low grade myelodysplastic syndromes: Role of cytokines

✍ M. Di Stefano; A. Cortelezzi; P. Musto; R. Calori; M. Pomati; C. Cattaneo; M. Ca 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Recombinant human erythropoietin therapy

Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis

✍ Bradley A. Warady; Richard J. Sabath; Christine A. Smith; Uri Alon; Stanley Hell 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 711 KB

Neurological toxicity of long-term (>1 y

Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma

✍ Patrizia Tosi; Elena Zamagni; Claudia Cellini; Rosaria Plasmati; Delia Cangini; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Long-term effects of recombinant human e

Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis

✍ Juan J. Díez; Pedro Iglesias; Julia Sastre; Abelardo Aguilera; María A. Bajo; Ja 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 772 KB

237 The effectiveness and tolerability o

237 The effectiveness and tolerability of recombinant human erythropoietin (Epoetin alfa) in patients with multiple myeloma refractory to chemotherapy

✍ F. Dammacco; G. Caatoldi; B. Grassi; C. Bernasooni; G. Perona 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Prophylactic recombinant erythropoietin

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis

✍ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st